Literature DB >> 4528431

Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.

R T O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4528431     DOI： 10.1111/j.1749-6632.1974.tb20588.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  13 in total

1.  Haemoglobinopathies. The pathophysiology of beta-thalassaemia major.

Authors:  C B Modell
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

Review 2.  Current concepts in the management of thalassemia.

Authors:  R S Festa
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

3.  Survival and desferrioxamine in thalassaemia major.

Authors:  J A Murray
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

4.  Inadequate dietary intake in patients with thalassemia.

Authors:  Ellen B Fung; Yan Xu; Felicia Trachtenberg; Isaac Odame; Janet L Kwiatkowski; Ellis J Neufeld; Alexis A Thompson; Jeanne Boudreaux; Charles T Quinn; Elliott P Vichinsky
Journal:  J Acad Nutr Diet       Date:  2012-05-01       Impact factor: 4.910

5.  Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.

Authors:  Venée N Tubman; Ellen B Fung; Maria Vogiatzi; Alexis A Thompson; Zora R Rogers; Ellis J Neufeld; Janet L Kwiatkowski
Journal:  J Pediatr Hematol Oncol       Date:  2015-04       Impact factor: 1.289

6.  Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.

Authors:  B S van Asbeck; J H Marcelis; J J Marx; A Struyvenberg; J H van Kats; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

7.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04

8.  Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.

Authors:  B S van Asbeck; J H Marcelis; J H van Kats; E Y Jaarsma; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

9.  Reducing power and iron chelating property of Terminalia chebula (Retz.) alleviates iron induced liver toxicity in mice.

Authors:  Rhitajit Sarkar; Bibhabasu Hazra; Nripendranath Mandal
Journal:  BMC Complement Altern Med       Date:  2012-08-31       Impact factor: 3.659

10.  Hepatoprotective Potential of Caesalpinia crista against Iron-Overload-Induced Liver Toxicity in Mice.

Authors:  Rhitajit Sarkar; Bibhabasu Hazra; Nripendranath Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-17       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.